Mouse Anti-FXN Recombinant Antibody (CBXF-3686) (CBMAB-F2777-CQ)

Name: Mouse Anti-FXN Recombinant Antibody (CBXF-3686)
SKU: CBMAB-F2777-CQ
Rating: 5 (1 reviews)

See all FXN antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Host Animal

Mouse

Clone

CBXF-3686

Application

WB, FC, IHC, IF, IHC-P

Immunogen

Full length human recombinant protein of human FXN (NP_000135)

Specificity

Human

Antibody Isotype

IgG1

Clonality

Monoclonal

Application Notes

The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Storage

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

More Infomation

Target

Full Name

Frataxin

Introduction

This nuclear gene encodes a mitochondrial protein which belongs to the FRATAXIN family. The protein functions in regulating mitochondrial iron transport and respiration. The expansion of intronic trinucleotide repeat GAA from 8-33 repeats to>90 repeats results in Friedreich ataxia. Alternative splicing results in multiple transcript variants.

Entrez Gene ID

2395

UniProt ID

Q16595

Alternative Names

Frataxin; Friedreich Ataxia Protein; FRDA; X25; Frataxin, Mitochondrial; Friedreich Ataxia;

Function

Promotes the biosynthesis of heme and assembly and repair of iron-sulfur clusters by delivering Fe2+ to proteins involved in these pathways. May play a role in the protection against iron-catalyzed oxidative stress through its ability to catalyze the oxidation of Fe2+ to Fe3+; the oligomeric form but not the monomeric form has in vitro ferroxidase activity. May be able to store large amounts of iron in the form of a ferrihydrite mineral by oligomerization; however, the physiological relevance is unsure as reports are conflicting and the function has only been shown using heterologous overexpression systems. Modulates the RNA-binding activity of ACO1.

Biological Process

Adult walking behavior Source: Ensembl
Cellular iron ion homeostasis Source: BHF-UCL
Cellular response to hydrogen peroxide Source: UniProtKB
Embryo development ending in birth or egg hatching Source: Ensembl
Heme biosynthetic process Source: BHF-UCL
Ion transport Source: UniProtKB-KW
Iron incorporation into metallo-sulfur cluster Source: BHF-UCL
Iron-sulfur cluster assembly Source: FlyBase
Mitochondrion organization Source: Ensembl
Negative regulation of apoptotic process Source: UniProtKB
Negative regulation of multicellular organism growth Source: Ensembl
Negative regulation of organ growth Source: Ensembl
Negative regulation of release of cytochrome c from mitochondria Source: UniProtKB
Oxidative phosphorylation Source: Ensembl
Positive regulation of aconitate hydratase activity Source: BHF-UCL
Positive regulation of catalytic activity Source: BHF-UCL
Positive regulation of cell growth Source: BHF-UCL
Positive regulation of cell population proliferation Source: BHF-UCL
Positive regulation of lyase activity Source: UniProtKB
Positive regulation of succinate dehydrogenase activity Source: BHF-UCL
Proprioception Source: Ensembl
Protein autoprocessing Source: BHF-UCL
Regulation of ferrochelatase activity Source: BHF-UCL
Response to iron ion Source: BHF-UCL

Cellular Location

Mitochondrion; Cytosol. PubMed:18725397 reports localization exclusively in mitochondria.

Involvement in disease

Friedreich ataxia (FRDA):
Autosomal recessive, progressive degenerative disease characterized by neurodegeneration and cardiomyopathy it is the most common inherited ataxia. The disorder is usually manifest before adolescence and is generally characterized by incoordination of limb movements, dysarthria, nystagmus, diminished or absent tendon reflexes, Babinski sign, impairment of position and vibratory senses, scoliosis, pes cavus, and hammer toe. In most patients, FRDA is due to GAA triplet repeat expansions in the first intron of the frataxin gene. But in some cases the disease is due to mutations in the coding region.

PTM

Processed in two steps by mitochondrial processing peptidase (MPP). MPP first cleaves the precursor to intermediate form and subsequently converts the intermediate to yield frataxin mature form (frataxin(81-210)) which is the predominant form. The additional forms, frataxin(56-210) and frataxin(78-210), seem to be produced when the normal maturation process is impaired; their physiological relevance is unsure.

Hackett, P. T., Jia, X., Li, L., & Ward, D. M. (2022). Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich’s ataxia. Journal of Biological Chemistry, 298(6).

Medina-Carbonero, M., Sanz-Alcázar, A., Britti, E., Delaspre, F., Cabiscol, E., Ros, J., & Tamarit, J. (2022). Mice harboring the FXN I151F pathological point mutation present decreased frataxin levels, a Friedreich ataxia-like phenotype, and mitochondrial alterations. Cellular and Molecular Life Sciences, 79(2), 74.

Culley, M. K., Zhao, J., Tai, Y. Y., Tang, Y., Perk, D., Negi, V., ... & Chan, S. Y. (2021). Frataxin deficiency promotes endothelial senescence in pulmonary hypertension. The Journal of Clinical Investigation, 131(11).

Doni, D., Rigoni, G., Palumbo, E., Baschiera, E., Peruzzo, R., De Rosa, E., ... & Costantini, P. (2021). The displacement of frataxin from the mitochondrial cristae correlates with abnormal respiratory supercomplexes formation and bioenergetic defects in cells of Friedreich ataxia patients. The FASEB Journal, 35(3), e21362.

Li, J., Li, Y., Wang, J., Gonzalez, T. J., Asokan, A., Napierala, J. S., & Napierala, M. (2020). Defining transcription regulatory elements in the human Frataxin gene: implications for gene therapy. Human gene therapy, 31(15-16), 839-851.

Du, J., Zhou, Y., Li, Y., Xia, J., Chen, Y., Chen, S., ... & Wang, Y. (2020). Identification of Frataxin as a regulator of ferroptosis. Redox Biology, 32, 101483.

Maio, N., Jain, A., & Rouault, T. A. (2020). Mammalian iron–sulfur cluster biogenesis: recent insights into the roles of frataxin, acyl carrier protein and ATPase-mediated transfer to recipient proteins. Current opinion in chemical biology, 55, 34-44.

Patra, S., & Barondeau, D. P. (2019). Mechanism of activation of the human cysteine desulfurase complex by frataxin. Proceedings of the National Academy of Sciences, 116(39), 19421-19430.

Fox, N. G., Yu, X., Feng, X., Bailey, H. J., Martelli, A., Nabhan, J. F., ... & Han, S. (2019). Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism. Nature communications, 10(1), 2210.

Britti, E., Delaspre, F., Feldman, A., Osborne, M., Greif, H., Tamarit, J., & Ros, J. (2018). Frataxin‐deficient neurons and mice models of Friedreich ataxia are improved by TAT‐MTS cs‐FXN treatment. Journal of cellular and molecular medicine, 22(2), 834-848.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Mouse Anti-FXN Recombinant Antibody (CBXF-3686)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Antibody Pairs

FXN Matched Antibody Pair (457) (CAT#: APMAB-457LY)

Related Products

Mouse Anti-FXN Recombinant Antibody (CBXF-2266) (CAT#: CBMAB-F1521-CQ)

Mouse Anti-FXN Recombinant Antibody (CBXF-3613) (CAT#: CBMAB-F2843-CQ)

Mouse Anti-FXN Recombinant Antibody (CBXF-3779) (CAT#: CBMAB-F2501-CQ)

FXN Matched Antibody Pair (457) (CAT#: APMAB-457LY)

Mouse Anti-FXN (The first part of exon 4 of frataxin) Recombinant Antibody (CBXF-3243) (CAT#: CBMAB-F3937-CQ)

Mouse Anti-FXN Recombinant Antibody (CBXF-3585) (CAT#: CBMAB-F2216-CQ)

Mouse Anti-FXN Recombinant Antibody (1E11) (CAT#: CBMAB-F2744-CQ)

Mouse Anti-FXN (AA 91-200) Recombinant Antibody (CBXF-3244) (CAT#: CBMAB-F3938-CQ)

Mouse Anti-FXN Recombinant Antibody (CBXF-3789) (CAT#: CBMAB-F0635-CQ)

Recombinant Mouse Anti-FXN Recombinant Antibody (1G2) (CAT#: CBMAB-XB0482-YC)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry